Streptomyces sparsogenes Owen et al. (ATCC® 25498)

Strain Designations: ISP 5356 [CBS 672.69, CBS 958.69, IFO 13086, KCC S-0517, NCIB 9449, NRRL 2940; UC 2474, RIA 1278]  /  Type Strain: yes  /  Biosafety Level: 1

Strain Designations ISP 5356 [CBS 672.69, CBS 958.69, IFO 13086, KCC S-0517, NCIB 9449, NRRL 2940; UC 2474, RIA 1278]
Application
Produces sparsomycin
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain yes (type strain)
Comments
Streptomyces violaceusniger
Medium ATCC® Medium 527: Inorganic salts starch agar (ISP Medium 4)
Growth Conditions
Temperature: 26.0°C
Name of Depositor EB Shirling
Chain of Custody
ATCC <<--EB Shirling<<--NRRL 2940 <<--- Upjohn Co. UC 2474
References

Owen SP, et al. Sparsomycin, a new antitumor antibiotic. I. Discovery and biological properties. Antimicrob. Agents Chemother. 1962: 772-779, 1963.

Shirling EB, Gottlieb D. Cooperative description of type cultures of Streptomyces. IV. Species descriptions from the second, third and fourth studies. Int J Syst Bacteriol 19: 391-512, 1969.

. . Bergey's Manual Syst. Bacteriol. 4: 2476, 1989.

Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.

type strain

type strain